Endocrinologist, Clinical Assistant Professor Indiana University School of Medicine
Presentation summary: • Highlight factors beyond BMD that contribute to fracture risk, including the need to improve bone architecture & strength • Expand understanding how to identify risk factors that reclassifies a patient to be defined as VHFR in alignment with Guidelines and the ASBMR Task Force Position Statement
Content includes: • Assessing Fracture Risk • ASBMR/BHOF position statement • Bone architecture & strength • Duel mechanism of action • EVENITY data from FRAME & ARCH
